Code | 20200 | ||||||||||
MA number | EU/1/09/555/002 | ||||||||||
Product Form: | tbl flm 14x75 mg (bli.OPA/Al/PVC/Al) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | TAD Pharma GmbH, Germany | ||||||||||
Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 23.09.2009 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 06.12.2021 |